- Home
- UAL vs TEVA Comparison
UAL vs TEVA Comparison
Compare UAL & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAL
- TEVA
- Stock Information
- Founded
- UAL 1934
- TEVA 1901
- Country
- UAL United States
- TEVA Israel
- Employees
- UAL N/A
- TEVA N/A
- Industry
- UAL Air Freight/Delivery Services
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- UAL Consumer Discretionary
- TEVA Health Care
- Exchange
- UAL Nasdaq
- TEVA Nasdaq
- Market Cap
- UAL 22.3B
- TEVA 20.1B
- IPO Year
- UAL N/A
- TEVA N/A
- Fundamental
- Price
- UAL $82.10
- TEVA $17.15
- Analyst Decision
- UAL Strong Buy
- TEVA Strong Buy
- Analyst Count
- UAL 15
- TEVA 8
- Target Price
- UAL $104.36
- TEVA $24.50
- AVG Volume (30 Days)
- UAL 7.0M
- TEVA 10.5M
- Earning Date
- UAL 07-16-2025
- TEVA 07-30-2025
- Dividend Yield
- UAL N/A
- TEVA N/A
- EPS Growth
- UAL 35.24
- TEVA N/A
- EPS
- UAL 10.95
- TEVA N/A
- Revenue
- UAL $57,737,000,000.00
- TEVA $16,616,000,000.00
- Revenue This Year
- UAL $3.95
- TEVA $5.69
- Revenue Next Year
- UAL $7.43
- TEVA N/A
- P/E Ratio
- UAL $7.52
- TEVA N/A
- Revenue Growth
- UAL 5.31
- TEVA 3.82
- 52 Week Low
- UAL $37.02
- TEVA $12.47
- 52 Week High
- UAL $116.00
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- UAL 59.86
- TEVA 50.50
- Support Level
- UAL $78.33
- TEVA $16.55
- Resistance Level
- UAL $80.78
- TEVA $16.95
- Average True Range (ATR)
- UAL 2.86
- TEVA 0.43
- MACD
- UAL 0.42
- TEVA -0.06
- Stochastic Oscillator
- UAL 92.64
- TEVA 45.04
About UAL United Airlines Holdings Inc.
United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel than its large US peers.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.